Bausch + Lomb Total Long-Term Assets 2021-2025 | BLCO

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Bausch + Lomb total long-term assets from 2021 to 2025. Total long-term assets can be defined as the sum of all assets classified as non-current

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Bausch + Lomb total long-term assets from 2021 to 2025. Total long-term assets can be defined as the sum of all assets classified as non-current

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$141.5B
CVS Health (CVS)	$81.4B
Elevance Health (ELV)	$76.8B
Cencora (COR)	$57.6B
DiDi Global (DIDIY)	$25.2B
Natera (NTRA)	$21.6B
Labcorp Holdings (LH)	$20.9B
BioMerieux (BMXMF)	$16.9B
EUROFINS SCIENT (ERFSF)	$13.3B
CochLear (CHEOY)	$13B
Solventum (SOLV)	$12.8B
ICON (ICLR)	$12.1B
Revvity (RVTY)	$11.6B
Viatris (VTRS)	$10.7B
Medpace Holdings (MEDP)	$9.2B
Avantor (AVTR)	$9B
Sonic Healthcare (SKHHY)	$8.8B
HealthEquity (HQY)	$8.4B
Charles River Laboratories (CRL)	$7.8B
Caris Life Sciences,�Inc (CAI)	$7.1B
Amplifon S.p.A (AMFPF)	$5.4B
BrightSpring Health Services (BTSG)	$3.6B
Sotera Health (SHC)	$3.3B
Surgery Partners (SGRY)	$2.9B
Alignment Healthcare (ALHC)	$2.7B
Concentras Parent (CON)	$2.6B
Organon (OGN)	$2.6B
GeneDx Holdings (WGS)	$2.4B
Ardent Health (ARDT)	$2.1B
Progyny (PGNY)	$2B